RESUMO
BACKGROUND AND PURPOSE: Multifocal glioblastomas (ie, glioblastomas with multiple foci, unconnected in postcontrast pretreatment T1-weighted images) represent a challenge in clinical practice due to their poor prognosis. We wished to obtain imaging biomarkers with prognostic value that have not been found previously. MATERIALS AND METHODS: A retrospective review of 1155 patients with glioblastomas from 10 local institutions during 2006-2017 provided 97 patients satisfying the inclusion criteria of the study and classified as having multifocal glioblastomas. Tumors were segmented and morphologic features were computed using different methodologies: 1) measured on the largest focus, 2) aggregating the different foci as a whole, and 3) recording the extreme value obtained for each focus. Kaplan-Meier, Cox proportional hazards, correlations, and Harrell concordance indices (c-indices) were used for the statistical analysis. RESULTS: Age (P < .001, hazard ratio = 2.11, c-index = 0.705), surgery (P < .001, hazard ratio = 2.04, c-index = 0.712), contrast-enhancing rim width (P < .001, hazard ratio = 2.15, c-index = 0.704), and surface regularity (P = .021, hazard ratio = 1.66, c-index = 0.639) measured on the largest focus were significant independent predictors of survival. Maximum contrast-enhancing rim width (P = .002, hazard ratio = 2.05, c-index = 0.668) and minimal surface regularity (P = .036, hazard ratio = 1.64, c-index = 0.600) were also significant. A multivariate model using age, surgery, and contrast-enhancing rim width measured on the largest foci classified multifocal glioblastomas into groups with different outcomes (P < .001, hazard ratio = 3.00, c-index = 0.853, median survival difference = 10.55 months). Moreover, quartiles with the highest and lowest individual prognostic scores based on the focus with the largest volume and surgery were identified as extreme groups in terms of survival (P < .001, hazard ratio = 18.67, c-index = 0.967). CONCLUSIONS: A prognostic model incorporating imaging findings on pretreatment postcontrast T1-weighted MRI classified patients with glioblastoma into different prognostic groups.
Assuntos
Neoplasias Encefálicas/classificação , Neoplasias Encefálicas/patologia , Glioblastoma/classificação , Glioblastoma/patologia , Adulto , Idoso , Neoplasias Encefálicas/diagnóstico por imagem , Feminino , Glioblastoma/diagnóstico por imagem , Humanos , Imageamento por Ressonância Magnética/métodos , Masculino , Pessoa de Meia-Idade , Prognóstico , Modelos de Riscos Proporcionais , Estudos Retrospectivos , Análise de SobrevidaAssuntos
Fibroma , Mesentério , Neoplasias Peritoneais , Doença Aguda , Idoso , Colecistite/cirurgia , Feminino , Fibroma/diagnóstico , Fibroma/cirurgia , Humanos , Neoplasias Peritoneais/diagnóstico , Neoplasias Peritoneais/cirurgia , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/cirurgiaAssuntos
Humanos , Feminino , Pessoa de Meia-Idade , Fibroma/diagnóstico , Fibroma/cirurgia , Mesentério/patologia , Neoplasias Peritoneais/diagnóstico , Neoplasias Peritoneais/cirurgia , Colecistectomia/métodos , Doença Aguda , Colecistite/cirurgia , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/cirurgia , Leucocitose/complicações , Radiografia Abdominal/métodosRESUMO
Cirrhosis secondary to hepatitis C virus (HCV) is one of the most frequent indications for liver transplantation. During recent years, the age of donors has increased, which has led to a worse prognosis for persons undergoing transplantations because of this virus. In this study, we analyzed the 93 transplantations performed during a 6-year period (2000-2005) due to HCV, dividing them into 2 groups according to donor age: <60 years (group A) and >/=60 years (group B). We examined graft and recipient survivals with a mean follow-up of 34 months. Recipient survival among group A was 61% compared with 57% among Group B, the difference being greater if we excluded the initial months after transplantation, since this eliminated the complications inherent to the intervention. Graft survival, according to the Knodell histological activity index, was summarized as: 55.7% histological recurrence, 16.7% fibrosis, and 21% cirrhosis among group A versus 65.6%, 25%, and 18.7%, respectively, among group B. In conclusion, there was improved survival and disease progression was slower among group A compared with group B, suggesting that donor age was an important factor; patient and graft survivals fell progressively with increased donor age.
Assuntos
Hepatite C/cirurgia , Cirrose Hepática/cirurgia , Transplante de Fígado/mortalidade , Transplante de Fígado/fisiologia , Doadores de Tecidos/estatística & dados numéricos , Fatores Etários , Biópsia , Sobrevivência de Enxerto/fisiologia , Humanos , Cirrose Hepática/virologia , Transplante de Fígado/patologia , Pessoa de Meia-Idade , Recidiva , Estudos Retrospectivos , Análise de Sobrevida , Sobreviventes , Fatores de TempoRESUMO
No disponible
Assuntos
Masculino , Idoso , Humanos , Pneumoperitônio/etiologia , Gastrostomia/efeitos adversos , Tomografia Computadorizada por Raios X , Neoplasias de Cabeça e Pescoço/complicações , Neoplasias Tonsilares/complicaçõesAssuntos
Doenças dos Ductos Biliares/patologia , Ducto Hepático Comum/patologia , Litíase/patologia , Idoso , Doenças dos Ductos Biliares/diagnóstico por imagem , Doenças dos Ductos Biliares/cirurgia , Procedimentos Cirúrgicos do Sistema Biliar , Colangiopancreatografia Retrógrada Endoscópica , Diagnóstico Diferencial , Feminino , Ducto Hepático Comum/diagnóstico por imagem , Ducto Hepático Comum/cirurgia , Humanos , Litíase/diagnóstico por imagem , Litíase/cirurgia , Resultado do TratamentoRESUMO
No disponible